ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan
· Delayed Price · Currency is TWD 79.50
+2.20 (2.85%)
Aug 15, 2025, 1:59 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 4.81 billion as of August 15, 2025. Its market cap has increased by 196.05% in one year.
Market Cap
4.81B
Enterprise Value
4.33B
Revenue
44.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
79.50
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 4.81B, an increase of 248.65%. That is a compound annual growth rate of 36.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 4.81B | 207.63% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 224.90B |
| PharmaEssentia | 167.97B |
| Bora Pharmaceuticals Co., LTD. | 97.17B |
| Lotus Pharmaceutical | 52.73B |
| Oneness Biotech | 34.00B |
| Lumosa Therapeutics | 28.78B |
| Polaris Group | 27.23B |
| Center Laboratories | 26.78B |